The apheresis equipment market size has grown rapidly in recent years. It will grow from $4.33 billion in 2025 to $4.88 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to limited access to automated apheresis equipment, growing prevalence of renal and hematologic disorders, increasing blood donation initiatives, adoption of centrifugation-based systems, regulatory guidelines for patient safety.
The apheresis equipment market size is expected to see rapid growth in the next few years. It will grow to $7.77 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to technological advancements in photopheresis and ldl apheresis, rising investment in automated and membrane-based systems, expansion of hospital and asc infrastructure, increasing demand for personalized and precision therapies, growing awareness and adoption of therapeutic apheresis globally. Major trends in the forecast period include rising demand for automated apheresis systems, increasing use of apheresis in hematology and renal therapies, growing adoption of membrane filtration technologies, expansion of blood donation and therapeutic centers, emphasis on patient safety and quality control standards.
The increasing incidence of blood disorders is anticipated to drive the growth of the apheresis equipment market in the coming years. Hemophilia is an inherited blood condition marked by a lack of clotting factors, resulting in extended bleeding episodes and the need for specialized therapies such as plasma and clotting factor replacement. The growing hemophilia patient population is attributed to better diagnostic capabilities, improved reporting practices, and overall population growth. Apheresis equipment plays a crucial role in the effective management of hemophilia by allowing accurate separation and collection of specific blood components for therapeutic purposes, thereby enhancing treatment effectiveness and patient outcomes. For example, in October 2024, according to the World Federation of Hemophilia, a Canada-based organization, there were 390,630 identified hemophilia patients across 119 countries in 2023. Hence, the rising prevalence of blood disorders is contributing to the expansion of the apheresis equipment market.
Companies in the apheresis equipment market are focusing on developing innovative products, such as advanced venous access techniques, to enhance patient comfort, reduce procedure duration, and improve treatment efficiency. Venous access techniques involve technologies designed to make the insertion of needles or catheters into veins safer, easier, and more efficient. For instance, in April 2023, Fresenius Kabi AG, a Germany-based medical technology company, introduced a single-needle venous access option for its Amicus extracorporeal photopheresis (ECP) system. This solution allows clinicians to seamlessly switch between single-needle and double-needle access during procedures, includes advanced software upgrades, and utilizes a single-use disposable kit for easy setup, further streamlining clinical workflows. It enhances patient comfort, minimizes the risk of complications, and improves the overall efficiency of apheresis treatments.
In November 2024, Macopharma International Group S.A.S., a France-based medical device company, acquired Lmb Technologie GmbH for an undisclosed amount. Through this acquisition, Macopharma seeks to expand its blood processing solutions, strengthen its global presence, and drive growth by integrating Lmb Technologie’s expertise. Lmb Technologie GmbH, based in Germany, specializes in providing apheresis equipment.
Major companies operating in the apheresis equipment market are Asahi Kasei Medical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Terumo Blood and Cell Technologies Inc., Kaneka Corporation, Sumitomo Bakelite Co. Ltd., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma S.A., B. Braun Melsungen AG, Cerus Corporation, Infomed S.A., Medica S.p.A., Baihe Medical Technology Co. Ltd., Brightwake Limited, Kawasumi Laboratories Inc., Haier Biomedical Co. Ltd., Nigale Biomedical Inc., Apheresis Technologies LLC.
North America was the largest region in the apheresis equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the apheresis equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the apheresis equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the apheresis equipment market by increasing the cost of imported medical devices, precision components, and filtration systems, thereby affecting pricing and procurement strategies for hospitals and blood donation centers. Segments such as photopheresis equipment and membrane filtration systems are most affected, particularly in regions like Asia-Pacific and North America where imports are significant. While tariffs create short-term cost pressures and supply chain disruptions, they also incentivize local manufacturing, encourage innovation in device design, and strengthen domestic production capabilities over time.
The apheresis equipment market research report is one of a series of new reports that provides apheresis equipment market statistics, including apheresis equipment industry global market size, regional shares, competitors with a apheresis equipment market share, detailed apheresis equipment market segments, market trends and opportunities, and any further data you may need to thrive in the apheresis equipment industry. This apheresis equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Apheresis equipment refers to specialized medical devices designed to isolate and extract specific components from blood while returning the remaining components to the donor or patient. These devices are used to separate and remove particular harmful or therapeutic blood elements, such as plasma, white blood cells, platelets, or stem cells, from a donor or patient.
The key types of apheresis equipment include plasmapheresis equipment, photopheresis equipment, low-density lipoprotein (LDL) apheresis equipment, and others. Plasmapheresis equipment is a medical device that isolates and removes plasma from the blood to treat autoimmune and plasma-related disorders, thereby supporting patient recovery. The technologies employed in this equipment include centrifugation and membrane filtration. These devices are applied in areas such as renal diseases, hematology, neurology, and more, with key end-users including hospitals, ambulatory surgical centers (ASCs), blood donation centers, and other healthcare facilities.
The apheresis equipment market consists of revenues earned by entities by providing services such as blood component separation, plasma exchange, photopheresis treatment, therapeutic plasma exchange, and related maintenance and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The apheresis equipment market also includes sales of centrifugal apheresis machines, membrane filtration devices, blood cell separators, plasma separators, and platelet separators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The apheresis equipment market size is expected to see rapid growth in the next few years. It will grow to $7.77 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to technological advancements in photopheresis and ldl apheresis, rising investment in automated and membrane-based systems, expansion of hospital and asc infrastructure, increasing demand for personalized and precision therapies, growing awareness and adoption of therapeutic apheresis globally. Major trends in the forecast period include rising demand for automated apheresis systems, increasing use of apheresis in hematology and renal therapies, growing adoption of membrane filtration technologies, expansion of blood donation and therapeutic centers, emphasis on patient safety and quality control standards.
The increasing incidence of blood disorders is anticipated to drive the growth of the apheresis equipment market in the coming years. Hemophilia is an inherited blood condition marked by a lack of clotting factors, resulting in extended bleeding episodes and the need for specialized therapies such as plasma and clotting factor replacement. The growing hemophilia patient population is attributed to better diagnostic capabilities, improved reporting practices, and overall population growth. Apheresis equipment plays a crucial role in the effective management of hemophilia by allowing accurate separation and collection of specific blood components for therapeutic purposes, thereby enhancing treatment effectiveness and patient outcomes. For example, in October 2024, according to the World Federation of Hemophilia, a Canada-based organization, there were 390,630 identified hemophilia patients across 119 countries in 2023. Hence, the rising prevalence of blood disorders is contributing to the expansion of the apheresis equipment market.
Companies in the apheresis equipment market are focusing on developing innovative products, such as advanced venous access techniques, to enhance patient comfort, reduce procedure duration, and improve treatment efficiency. Venous access techniques involve technologies designed to make the insertion of needles or catheters into veins safer, easier, and more efficient. For instance, in April 2023, Fresenius Kabi AG, a Germany-based medical technology company, introduced a single-needle venous access option for its Amicus extracorporeal photopheresis (ECP) system. This solution allows clinicians to seamlessly switch between single-needle and double-needle access during procedures, includes advanced software upgrades, and utilizes a single-use disposable kit for easy setup, further streamlining clinical workflows. It enhances patient comfort, minimizes the risk of complications, and improves the overall efficiency of apheresis treatments.
In November 2024, Macopharma International Group S.A.S., a France-based medical device company, acquired Lmb Technologie GmbH for an undisclosed amount. Through this acquisition, Macopharma seeks to expand its blood processing solutions, strengthen its global presence, and drive growth by integrating Lmb Technologie’s expertise. Lmb Technologie GmbH, based in Germany, specializes in providing apheresis equipment.
Major companies operating in the apheresis equipment market are Asahi Kasei Medical Co. Ltd., Baxter International Inc., Fresenius Kabi AG, Terumo Blood and Cell Technologies Inc., Kaneka Corporation, Sumitomo Bakelite Co. Ltd., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma S.A., B. Braun Melsungen AG, Cerus Corporation, Infomed S.A., Medica S.p.A., Baihe Medical Technology Co. Ltd., Brightwake Limited, Kawasumi Laboratories Inc., Haier Biomedical Co. Ltd., Nigale Biomedical Inc., Apheresis Technologies LLC.
North America was the largest region in the apheresis equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the apheresis equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the apheresis equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the apheresis equipment market by increasing the cost of imported medical devices, precision components, and filtration systems, thereby affecting pricing and procurement strategies for hospitals and blood donation centers. Segments such as photopheresis equipment and membrane filtration systems are most affected, particularly in regions like Asia-Pacific and North America where imports are significant. While tariffs create short-term cost pressures and supply chain disruptions, they also incentivize local manufacturing, encourage innovation in device design, and strengthen domestic production capabilities over time.
The apheresis equipment market research report is one of a series of new reports that provides apheresis equipment market statistics, including apheresis equipment industry global market size, regional shares, competitors with a apheresis equipment market share, detailed apheresis equipment market segments, market trends and opportunities, and any further data you may need to thrive in the apheresis equipment industry. This apheresis equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Apheresis equipment refers to specialized medical devices designed to isolate and extract specific components from blood while returning the remaining components to the donor or patient. These devices are used to separate and remove particular harmful or therapeutic blood elements, such as plasma, white blood cells, platelets, or stem cells, from a donor or patient.
The key types of apheresis equipment include plasmapheresis equipment, photopheresis equipment, low-density lipoprotein (LDL) apheresis equipment, and others. Plasmapheresis equipment is a medical device that isolates and removes plasma from the blood to treat autoimmune and plasma-related disorders, thereby supporting patient recovery. The technologies employed in this equipment include centrifugation and membrane filtration. These devices are applied in areas such as renal diseases, hematology, neurology, and more, with key end-users including hospitals, ambulatory surgical centers (ASCs), blood donation centers, and other healthcare facilities.
The apheresis equipment market consists of revenues earned by entities by providing services such as blood component separation, plasma exchange, photopheresis treatment, therapeutic plasma exchange, and related maintenance and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The apheresis equipment market also includes sales of centrifugal apheresis machines, membrane filtration devices, blood cell separators, plasma separators, and platelet separators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Apheresis Equipment Market Characteristics
3. Apheresis Equipment Market Supply Chain Analysis
4. Global Apheresis Equipment Market Trends and Strategies
5. Apheresis Equipment Market Analysis of End Use Industries
7. Global Apheresis Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Apheresis Equipment Total Addressable Market (TAM) Analysis for the Market
9. Apheresis Equipment Market Segmentation
10. Apheresis Equipment Market Regional and Country Analysis
11. Asia-Pacific Apheresis Equipment Market
12. China Apheresis Equipment Market
13. India Apheresis Equipment Market
14. Japan Apheresis Equipment Market
15. Australia Apheresis Equipment Market
16. Indonesia Apheresis Equipment Market
17. South Korea Apheresis Equipment Market
18. Taiwan Apheresis Equipment Market
19. South East Asia Apheresis Equipment Market
20. Western Europe Apheresis Equipment Market
21. UK Apheresis Equipment Market
22. Germany Apheresis Equipment Market
23. France Apheresis Equipment Market
24. Italy Apheresis Equipment Market
25. Spain Apheresis Equipment Market
26. Eastern Europe Apheresis Equipment Market
27. Russia Apheresis Equipment Market
28. North America Apheresis Equipment Market
29. USA Apheresis Equipment Market
30. Canada Apheresis Equipment Market
31. South America Apheresis Equipment Market
32. Brazil Apheresis Equipment Market
33. Middle East Apheresis Equipment Market
34. Africa Apheresis Equipment Market
36. Apheresis Equipment Market Competitive Landscape and Company Profiles
37. Apheresis Equipment Market Other Major and Innovative Companies
40. Apheresis Equipment Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Apheresis Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses apheresis equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for apheresis equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The apheresis equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Plasmapheresis Equipment; Photopheresis Equipment; Low-Density Lipoprotein (LDL) Apheresis Equipment; Other Product Types2) By Technology Type: Centrifugation; Membrane Filtration
3) By Application: Renal Diseases; Hematology; Neurology; Other Applications
4) By End User: Hospitals; Ambulatory Surgical Centers (ASCs); Blood Donation Centers; Other End Users
Subsegments:
1) By Plasmapheresis Equipment: Automated Plasmapheresis Systems; Manual Plasmapheresis Systems; Plasma Exchange Devices; Plasma Collection Devices; Plasma Filtration Systems2) By Photopheresis Equipment: Extracorporeal Photopheresis Systems; In Vivo Photopheresis Devices; Photoactivation Equipment
3) By Low-Density Lipoprotein (LDL) Apheresis Equipment: Cascade Filtration Systems; Immunoadsorption Systems; Selective Low-Density Lipoprotein Removal Devices
4) By Other Product Types: Leukapheresis Equipment; Red Blood Cell Apheresis Devices; Plateletpheresis Systems; Stem Cell Apheresis Devices
Companies Mentioned: Asahi Kasei Medical Co. Ltd.; Baxter International Inc.; Fresenius Kabi AG; Terumo Blood and Cell Technologies Inc.; Kaneka Corporation; Sumitomo Bakelite Co. Ltd.; Nikkiso Co. Ltd.; Haemonetics Corporation; Miltenyi Biotec GmbH; Macopharma S.A.; B. Braun Melsungen AG; Cerus Corporation; Infomed S.A.; Medica S.p.A.; Baihe Medical Technology Co. Ltd.; Brightwake Limited; Kawasumi Laboratories Inc.; Haier Biomedical Co. Ltd.; Nigale Biomedical Inc.; Apheresis Technologies LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Apheresis Equipment market report include:- Asahi Kasei Medical Co. Ltd.
- Baxter International Inc.
- Fresenius Kabi AG
- Terumo Blood and Cell Technologies Inc.
- Kaneka Corporation
- Sumitomo Bakelite Co. Ltd.
- Nikkiso Co. Ltd.
- Haemonetics Corporation
- Miltenyi Biotec GmbH
- Macopharma S.A.
- B. Braun Melsungen AG
- Cerus Corporation
- Infomed S.A.
- Medica S.p.A.
- Baihe Medical Technology Co. Ltd.
- Brightwake Limited
- Kawasumi Laboratories Inc.
- Haier Biomedical Co. Ltd.
- Nigale Biomedical Inc.
- Apheresis Technologies LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.88 Billion |
| Forecasted Market Value ( USD | $ 7.77 Billion |
| Compound Annual Growth Rate | 12.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
